BALA CYNWYD, PA / ACCESSWIRE / January 4, 2020 / Brodsky & Smith, LLC reminds investors of important approaching deadlines regarding class action lawsuits against the following companies for violations of federal securities laws. If you purchased any of the below-listed stocks during the referenced time periods and want to discuss your legal rights, please contact Marc Ackerman, Esquire or Jordan Schatz, Esquire at 877-534-2590. There is no cost or financial obligation to you.

MERIT MEDICAL SYSTEMS, INC. (MMSI)

Shares purchased between February 26, 2019 and October 30, 2019

Deadline: February 3, 2020

According to the complaint, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, salespeople, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights' products which, as late as July 2019, had zero orders during fiscal year 2019; and (c) in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis.

Additional information can be found at http://www.brodskysmith.com/?post_type=cases&p=13407&preview=true, or call 877-534-2590. No cost or obligation to you.

UNDER ARMOUR, INC. (NYSE:UA and UAA)

Shares purchased between August 3, 2016 and November 1, 2019

Deadline: January 6, 2020

According to the complaint, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) Under Armour shifted sales from quarter to quarter to appear healthier, including to keep pace with their long-running year-over-year 20% net revenue growth; (2) Under Armour had been under investigation by and cooperating with the DOJ and SEC since at least July 2017; and (3) as a result, the defendants' statements about Under Armour's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Additional information can be found at http://www.brodskysmith.com/cases/armour-inc-nyse-ua-uaa/, or call 877-534-2590. No cost or obligation to you.

BAXTER INTERNATIONAL (BAX)

Shares purchased between February 21, 2019 and October 23, 2019

Deadline: January 24, 2020

According to the complaint, throughout the Class Period, defendants misrepresented and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) Baxter lacked effective internal control over financial reporting; (3) as a result, Baxter's financial statements were misstated and would likely require correction or amendment; (4) due to Baxter's internal investigation, it would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on a Form 10-Q in a timely manner; and (5) as a result of the foregoing, defendants' statements about Baxter's business and operations lacked a reasonable basis.